Yanhong Gu
机构：Zhejiang University Medical College Affiliated Stomatological Hospital, Jiangsu Cancer Hospital, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-0379-0410
发表论文 155 篇 · 总被引 4564 次 · h-index 38
代表论文
- Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085 (2024 · Journal of Nanobiotechnology · 被引 39)
- Evaluating AI in medicine: a comparative analysis of expert and ChatGPT responses to colorectal cancer questions (2024 · Scientific Reports · 被引 36)
- Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors. (2024 · Journal of Clinical Oncology · 被引 36)
- Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial (2025 · Nature Medicine · 被引 30)
- PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 13)
- Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials (2025 · 癌症：英文版 · 被引 12)